Clinical Chemistry Siemens Point of Care - Urinalysis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 54: 1892-1899, 2008. First published August 21, 2008; 10.1373/clinchem.2008.108142
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2008.108142v1
54/11/1892    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arnaud, J.
Right arrow Articles by Taylor, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arnaud, J.
Right arrow Articles by Taylor, A.
(Clinical Chemistry. 2008;54:1892-1899.)
© 2008 American Association for Clinical Chemistry, Inc.


General Clinical Chemistry

Quality Specifications for the Determination of Copper, Zinc, and Selenium in Human Serum or Plasma: Evaluation of an Approach Based on Biological and Analytical Variation

Josiane Arnaud1,a, Jean-Philippe Weber2, Cas W. Weykamp3, Patrick J. Parsons4, Jurgen Angerer5, Eric Mairiaux6, Olav Mazarrasa7, Sinikka Valkonen8, Antonio Menditto9, Marina Patriarca9 and Andrew Taylor10

1 Département de Biologie Intégrée, Pôle de biologie, CHU de Grenoble, Grenoble, France; 2 Centre de Toxicologie, Institut National de Santé Publique du Québec, Québec, QC Canada; 3 MCA Laboratory, Queen Beatrix Hospital, The Netherlands; 4 Trace Elements Laboratory, Wadsworth Center, New York State Department of Health, Albany, NY; 5 Institute of Occupational, Social and Environmental Medicine, University of Erlangen-Nuernberg, Erlangen, Germany; 6 Bureau of Quality Assurance, Scientific Institute of Public Health, Brussels, Belgium; 7 Higiene Industrial, Centro de Seguridad y Salud en el Trabajo, Santander, Spain; 8 Biomonitoring Laboratory, Finnish Institute of Occupational Health, Helsinki, Finland; 9 Dipartimento di Sanità Alimentare e Animale, Istituto Superiore di Sanità, Roma, Italy; 10 Centre for Clinical Science and Measurement, School of Biomedical and Life Sciences, University of Surrey, Guildford, U.K.

aAddress correspondence to this author at: Département de Biologie Intégrée, Pôle de biologie, CHU de Grenoble, 38043 Grenoble cedex 9, France. Fax 33 4 76 76 58 21; e-mail JArnaud{at}chu-grenoble.fr.

Background: Trace element external quality assessment schemes monitor laboratory performance and provide a stimulus for improvement in accuracy. However, monitoring of participant performance varies according to the scheme and can lead to conflicting conclusions.

Methods: Quality specifications based on biological intra- and interindividual variability were calculated and compared to those currently used by various trace element external quality assessment schemes for plasma or serum copper, zinc, and selenium concentrations. For this purpose, we evaluated results reported by participating laboratories in different schemes, at key concentrations, using z scores.

Results: Minimal quality specifications developed from the biological intra- and interindividual variability were, for Cu, ±0.84 µmol/L or 12% of the assigned target concentration, whichever is greater; for Zn, ±1.20 µmol/L or 15% of the assigned target concentration, whichever is greater; and for Se, ±0.072 µmol/L or 12% of the assigned target concentration, whichever is greater. Reported performance of the participating laboratories depended on analyte, concentration, and the selected quality specification. In addition, the most commonly used methods for the determination of Cu, Zn, and Se may give different results.

Conclusions: The proposed minimal quality specifications based on biological variation are generally slightly less stringent than those currently in use, although they do not drastically change the performance evaluation in the different schemes. These specifications are a first step in the harmonization of practices among the schemes and remain to be evaluated.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Association for Clinical Chemistry.